Azacitidine Is Effective in Patients with Low / Intermediate-1 Risk Myelodysplastic Syndrome Managed in Community Based Practice: Preliminary Data From the Spanish Compassionate Use Registry.

Blood(2009)

Cited 0|Views1
No score
Abstract
Abstract 3801
More
Translated text
Key words
spanish compassionate use registry,patients
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined